Kuehne + Nagel and Roche develop environment-friendly transport solution
Roche, the global pharmaceutical group, has awarded Kuehne + Nagel a contract for its operations in Greece. As part of the agreement, the two companies have jointly developed an environment-friendly logistics solution which can substantially reduce CO2 emissions.
Usually, temperature-sensitive pharmaceutical products are transported by airfreight even over relatively short distances. For its business in Greece, however, the pharmaceutical company sought a more environment-friendly alternative to reduce CO2 emissions.
Based on Kuehne + Nagel's own 'KN PharmaChain' product, the two companies collaborated to develop a solution that ideally fulfils both the transport requirements of the temperature-sensitive products and achieves a reduction in CO2 emissions. 'KN PharmaChain' is a Europe-wide overland transport service specifically for pharmaceutical products. The service uses refrigerated trailers which permit exact temperature control and double-stack loading.
In the solution that has been developed, the shipments originating from various Roche production plants are consolidated by Kuehne + Nagel and transported to Greece under temperature controlled conditions. Compared with air transport, substantially less fuel is consumed for the same distance. Furthermore, the passive temperature control packaging, which was previously required, is no longer needed, thus reducing the volume of the shipment as well as saving packing material. As a result of these measures, the CO2 emissions are reduced by around 85%."The implementation of this project is the result of a close partnership in the fields of sustainability and green logistics," says Dirk Reich, Executive Vice President and member of the Management Board of Kuehne + Nagel International AG.